Kane Biotech Inc Cash Flow Conversion Efficiency

Latest as of December 2025: 0.912x

Kane Biotech Inc cash flow conversion efficiency. Based on the latest financial reports, Kane Biotech Inc (KNE) has a cash flow conversion efficiency ratio of 0.912x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CA$-680.61K ≈ $-492.35K USD) by net assets (CA$-746.54K ≈ $-540.04K USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Kane Biotech Inc (2003–2025)

Cash flow conversion efficiency of Kane Biotech Inc from 2003 to 2025. This chart illustrates how Kane Biotech Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Kane Biotech Inc (KNE) stock price for real-time trading data and today's change.

Kane Biotech Inc Cash Flow Conversion Ratio Explained

Kane Biotech Inc cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Kane Biotech Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Kane Biotech Inc ranked by their cash flow conversion efficiency. Also see market value of Kane Biotech Inc for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
Carmell Therapeutics Corporation NASDAQ:CTCX	0.198x
UNITH LTD. F:CM30	N/A
CARLSON INV. ZY 13 F:2HB	-0.001x
Strategem Capital Corp V:SGE	0.008x
Resources & Energy Group Ltd AU:REZ	-0.115x
OLB Group Inc NASDAQ:OLB	-0.148x
Acurx Pharmaceuticals LLC NASDAQ:ACXP	-0.210x
DSS Inc NYSE MKT:DSS	-0.290x

Annual Cash Flow Conversion Efficiency for Kane Biotech Inc (2003–2025)

The table below shows the annual cash flow conversion efficiency of Kane Biotech Inc from 2003 to 2025. Review cash generation quality of Kane Biotech Inc to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CA$-746.54K ≈ $-540.04K	CA$-3.26 Million ≈ $-2.35 Million	4.361x	+72.80%
2024-12-31	CA$-1.63 Million ≈ $-1.18 Million	CA$-4.11 Million ≈ $-2.97 Million	2.523x	+919.19%
2023-12-31	CA$-8.41 Million ≈ $-6.08 Million	CA$-2.08 Million ≈ $-1.51 Million	0.248x	-66.34%
2022-12-31	CA$-4.14 Million ≈ $-2.99 Million	CA$-3.04 Million ≈ $-2.20 Million	0.736x	-49.65%
2021-12-31	CA$-1.57 Million ≈ $-1.13 Million	CA$-2.29 Million ≈ $-1.66 Million	1.461x	+139.86%
2020-12-31	CA$1.07 Million ≈ $777.45K	CA$-3.94 Million ≈ $-2.85 Million	-3.665x	-221.02%
2019-12-31	CA$836.81K ≈ $605.33K	CA$-955.37K ≈ $-691.10K	-1.142x	-139.40%
2018-12-31	CA$-984.84K ≈ $-712.42K	CA$-2.85 Million ≈ $-2.06 Million	2.898x	+488.15%
2017-12-31	CA$2.74 Million ≈ $1.98 Million	CA$-2.04 Million ≈ $-1.48 Million	-0.747x	+57.43%
2016-12-31	CA$1.35 Million ≈ $974.76K	CA$-2.36 Million ≈ $-1.71 Million	-1.754x	+39.34%
2015-12-31	CA$480.25K ≈ $347.40K	CA$-1.39 Million ≈ $-1.00 Million	-2.891x	-265.11%
2014-12-31	CA$1.32 Million ≈ $958.43K	CA$-1.05 Million ≈ $-758.95K	-0.792x	+12.89%
2013-12-31	CA$1.28 Million ≈ $928.25K	CA$-1.17 Million ≈ $-843.79K	-0.909x	-84.75%
2012-12-31	CA$2.35 Million ≈ $1.70 Million	CA$-1.16 Million ≈ $-835.72K	-0.492x	-24.43%
2011-12-31	CA$2.38 Million ≈ $1.72 Million	CA$-940.30K ≈ $-680.20K	-0.395x	+41.91%
2010-12-31	CA$1.16 Million ≈ $841.74K	CA$-792.06K ≈ $-572.96K	-0.681x	-60.08%
2009-12-31	CA$1.80 Million ≈ $1.30 Million	CA$-764.26K ≈ $-552.85K	-0.425x	+40.87%
2008-12-31	CA$1.49 Million ≈ $1.08 Million	CA$-1.07 Million ≈ $-776.48K	-0.719x	-2.74%
2007-12-31	CA$1.14 Million ≈ $825.19K	CA$-798.38K ≈ $-577.53K	-0.700x	-18.27%
2006-12-31	CA$1.42 Million ≈ $1.03 Million	CA$-843.13K ≈ $-609.91K	-0.592x	+25.57%
2005-12-31	CA$1.02 Million ≈ $735.99K	CA$-808.87K ≈ $-585.12K	-0.795x	+32.63%
2004-12-31	CA$426.65K ≈ $308.63K	CA$-503.50K ≈ $-364.22K	-1.180x	-178.44%
2003-12-31	CA$955.27K ≈ $691.03K	CA$-404.87K ≈ $-292.88K	-0.424x	--

About Kane Biotech Inc

V:KNE Canada Biotechnology

Market Cap

$4.60 Million

CA$6.36 Million CAD

Market Cap Rank

#28689 Global

#1268 in Canada

Share Price

CA$0.04

Change (1 day)

+16.67%

52-Week Range

CA$0.02 - CA$0.05

All Time High

CA$0.40